Cullinan Oncology Company
Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2017
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
379700000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership